Matinas BioPharma Holdings MTNB
NYSE MTNB
$2.61 +0.17 (+6.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Matinas BioPharma Holdings (MTNB) Cash & Current Investments (2013 - 2026)

Updated

Matinas BioPharma Holdings (MTNB) recorded Cash & Current Investments of $761,000 in Q2 2026, down 88.3% from $6.53 million a year earlier and down 68.3% from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Matinas BioPharma Holdings reported Cash & Current Investments of $4 million, down 45.1% from FY2024.

  • Annual Cash & Current Investments has declined for five straight years, with a five-year compound annual growth rate of -41.6% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $7.28 million in FY2024 (-47.0%), $13.76 million in FY2023 (-52.2%), $28.76 million in FY2022 (-42.0%) and $49.62 million in FY2021 (-15.4%).
  • The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q2 2016.
  • On a year-over-year basis, Cash & Current Investments has declined for 22 consecutive quarters, with an average decline of 50.7% over the last eight quarters.
  • Across the past five years, year-over-year decline in Cash & Current Investments ran from 14.2% in Q3 2021 to 88.3% in Q2 2026.
  • Per Business Quant, the preceding three quarters came in at $2.4 million (Q1 2026), $4 million (Q4 2025) and $5.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Matinas BioPharma Holdings 16.72 Mn 4.13 Mn - 761,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 761,000.00
Mar 31, 2026 2.40 Mn
Dec 31, 2025 4.00 Mn
Sep 30, 2025 5.44 Mn
Jun 30, 2025 6.53 Mn
Mar 31, 2025 6.92 Mn
Dec 31, 2024 7.28 Mn
Sep 30, 2024 10.80 Mn
Jun 30, 2024 14.31 Mn
Mar 31, 2024 8.11 Mn
Dec 31, 2023 13.76 Mn
Sep 30, 2023 18.22 Mn
Jun 30, 2023 22.51 Mn
Mar 31, 2023 24.86 Mn
Dec 31, 2022 28.76 Mn
Sep 30, 2022 33.05 Mn
Jun 30, 2022 38.50 Mn
Mar 31, 2022 43.87 Mn
Dec 31, 2021 49.62 Mn
Sep 30, 2021 53.83 Mn
API Access

Matinas BioPharma Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MTNB&period=max&api_key=YOUR_API_KEY